<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36795333</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>24</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1434-9949</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Clinical rheumatology</Title><ISOAbbreviation>Clin Rheumatol</ISOAbbreviation></Journal><ArticleTitle>Clinical analysis of patients with systemic lupus erythematosus complicated with liver failure.</ArticleTitle><Pagination><StartPage>1545</StartPage><EndPage>1553</EndPage><MedlinePgn>1545-1553</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10067-023-06524-9</ELocationID><Abstract><AbstractText>The objective of this study is to analyze and summarize the characteristics of the clinical data of patients with systemic lupus erythematosus (SLE) complicated with liver failure, and to improve the cognition of the disease. The clinical data of patients with SLE complicated with liver failure hospitalized in Beijing Youan Hospital from January 2015 to December 2021 were collected retrospectively, including general information and laboratory examination data, and the clinical characteristics of the patients were summarized and analyzed. Twenty-one SLE patients with liver failure were analyzed. The diagnosis of liver involvement was earlier in 3 cases than that of SLE, and later in 2 cases. Eight patients were diagnosed with SLE and autoimmune hepatitis at the same time. The medical history is between 1&#xa0;month and 30&#xa0;years. This was the first case report of SLE complicated with liver failure. We found that: (1) among the 21 patients, organ cysts (liver and kidney cysts) were more common and the proportion of cholecystolithiasis and cholecystitis was higher than that in previous studies, but the proportion of renal function damage and joint involvement was lower. (2) The inflammatory reaction was more obvious in SLE patients with acute liver failure. The degree of liver function injury in SLE patients with autoimmune hepatitis was less than that in patients with other liver diseases. (3) The use of glucocorticoid in SLE patients with liver failure was worthy of further discussion. Key Points &#x2022; Patients with SLE complicated with liver failure have a lower proportion of renal impairment and joint involvement. &#x2022; The study firstly reported SLE patients with liver failure. &#x2022; Glucocorticoids in the treatment of SLE patients with liver failure are worthy of further discussion.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Lili</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-9877-5810</Identifier><AffiliationInfo><Affiliation>Integrated Traditional Chinese and Western Medicine Center, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Yin</LastName><ForeName>Ling</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Integrated Traditional Chinese and Western Medicine Center, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Lv</LastName><ForeName>Wenliang</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yitong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Integrated Traditional Chinese and Western Medicine Center, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Integrated Traditional Chinese and Western Medicine Center, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gou</LastName><ForeName>Chunyan</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Integrated Traditional Chinese and Western Medicine Center, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China. syyxgcy@ccmu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Jianhua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Integrated Traditional Chinese and Western Medicine Center, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China. hjhdoc@ccmu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xiaojun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Integrated Traditional Chinese and Western Medicine Center, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China. w_xiaojun@ccmu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2022-2-2186</GrantID><Agency>Capital Health Research and Development of Special Fund</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Clin Rheumatol</MedlineTA><NlmUniqueID>8211469</NlmUniqueID><ISSNLinking>0770-3198</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019693" MajorTopicYN="Y">Hepatitis, Autoimmune</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017093" MajorTopicYN="Y">Liver Failure</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008107" MajorTopicYN="Y">Liver Diseases</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Autoimmune hepatitis</Keyword><Keyword MajorTopicYN="N">Hormone therapy</Keyword><Keyword MajorTopicYN="N">Liver failure</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>24</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>16</Day><Hour>11</Hour><Minute>15</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36795333</ArticleId><ArticleId IdType="pmc">PMC10202995</ArticleId><ArticleId IdType="doi">10.1007/s10067-023-06524-9</ArticleId><ArticleId IdType="pii">10.1007/s10067-023-06524-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Suzuki A, Sekiyama N, Koito N, Ohosone Y, Mita S, Matsuoka Y, Irimajiri S. Liver disease in systemic lupus erythematosus. Nihon Rinsho Meneki Gakkai Kaishi. 1995;18:53&#x2013;59. doi: 10.2177/jsci.18.53.</Citation><ArticleIdList><ArticleId IdType="doi">10.2177/jsci.18.53</ArticleId><ArticleId IdType="pubmed">7553039</ArticleId></ArticleIdList></Reference><Reference><Citation>Kojima H, Uemura M, Sakurai S, Ann T, Ishii Y, Imazu H, Yoshikawa M, Ichijima K, Fukui H. Clinical features of liver disturbance in rheumatoid diseases: clinicopathological study with special reference to the cause of liver disturbance. J Gastroenterol. 2002;37:617&#x2013;625. doi: 10.1007/s005350200098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s005350200098</ArticleId><ArticleId IdType="pubmed">12203077</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L, Lin B, Lan Q, Liu L, Lu J, Zhang X, Zheng S, Xue Y. Presence of serum antinuclear antibodies does not impact outcomes in HBV-related acute-on-chronic liver failure. Can J Gastroenterol Hepatol. 2022;2022:7981338. doi: 10.1155/2022/7981338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/7981338</ArticleId><ArticleId IdType="pmc">PMC8881176</ArticleId><ArticleId IdType="pubmed">35223685</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrejevic S, Jeremic I, Sefik-Bukilica M, Nikolic M, Stojimirovic B, Bonaci-Nikolic B. Immunoserological parameters in SLE: high-avidity anti-dsDNA detected by ELISA are the most closely associated with the disease activity. Clin Rheumatol. 2013;32:1619&#x2013;1626. doi: 10.1007/s10067-013-2330-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-013-2330-3</ArticleId><ArticleId IdType="pubmed">23857662</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue R, Meng Q. The management of glucocorticoid therapy in liver failure. Front Immunol. 2019;10:2490. doi: 10.3389/fimmu.2019.02490.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02490</ArticleId><ArticleId IdType="pmc">PMC6843006</ArticleId><ArticleId IdType="pubmed">31749799</ArticleId></ArticleIdList></Reference><Reference><Citation>You H, Peng L, Zhao J, Fei Y, Wang Q, Zhang W, Li M, Zeng X. Clinical characteristics of systemic lupus erythematosus with cirrhosis. J Immunol Res. 2020;2020:2156762. doi: 10.1155/2020/2156762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/2156762</ArticleId><ArticleId IdType="pmc">PMC7260626</ArticleId><ArticleId IdType="pubmed">32537465</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdhary VR, Crowson CS, Poterucha JJ, Moder KG. Liver involvement in systemic lupus erythematosus: case review of 40 patients. J Rheumatol. 2008;35:2159&#x2013;2164. doi: 10.3899/jrheum.080336.</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.080336</ArticleId><ArticleId IdType="pubmed">18793002</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi A, Abe K, Yokokawa J, Iwadate H, Kobayashi H, Watanabe H, Irisawa A, Ohira H. Clinical features of liver dysfunction in collagen diseases. Hepatol Res. 2010;40:1092&#x2013;1097. doi: 10.1111/j.1872-034X.2010.00707.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1872-034X.2010.00707.x</ArticleId><ArticleId IdType="pubmed">20880057</ArticleId></ArticleIdList></Reference><Reference><Citation>Grover S, Rastogi A, Singh J, Rajbongshi A, Bihari C. Spectrum of histomorphologic findings in liver in patients with SLE: a review. Hepat Res Treat. 2014;2014:562979.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4130189</ArticleId><ArticleId IdType="pubmed">25136456</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng C, Wang Z, Wang L, Zhao J, Wang Q, Tian X, Li M, Zeng X. Clinical characteristics and prognosis of concomitant systemic lupus erythematosus and primary biliary cholangitis. Clin Rheumatol. 2021;40:1819&#x2013;1826. doi: 10.1007/s10067-020-05457-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-020-05457-x</ArticleId><ArticleId IdType="pubmed">33067770</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Lu Q, Zhu MQ, Huang C, Yu KK, Huang YX, Zhao X, Luo XG, Zheng JM. Lower level of complement component C3 and C3a in the plasma means poor outcome in the patients with hepatitis B virus related acute-on-chronic liver failure. BMC Gastroenterol. 2020;20:106. doi: 10.1186/s12876-020-01258-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12876-020-01258-3</ArticleId><ArticleId IdType="pmc">PMC7158068</ArticleId><ArticleId IdType="pubmed">32293297</ArticleId></ArticleIdList></Reference><Reference><Citation>Nashi RA, Shmerling RH. Antinuclear antibody testing for the diagnosis of systemic lupus erythematosus. Med Clin North Am. 2021;105:387&#x2013;396. doi: 10.1016/j.mcna.2020.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcna.2020.10.003</ArticleId><ArticleId IdType="pubmed">33589110</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez LA, Toloza SM, Alarcon GS. Impact of race and ethnicity in the course and outcome of systemic lupus erythematosus. Rheum Dis Clin North Am. 2014;40:433&#x2013;454. doi: 10.1016/j.rdc.2014.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rdc.2014.04.001</ArticleId><ArticleId IdType="pubmed">25034155</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A, Perl A. Redox control of integrin-mediated hepatic inflammation in systemic autoimmunity. Antioxid Redox Signal. 2022;36:367&#x2013;388. doi: 10.1089/ars.2021.0068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2021.0068</ArticleId><ArticleId IdType="pmc">PMC8982133</ArticleId><ArticleId IdType="pubmed">34036799</ArticleId></ArticleIdList></Reference><Reference><Citation>Leggett BA. The liver in systemic lupus erythematosus. J Gastroenterol Hepatol. 1993;8:84&#x2013;88. doi: 10.1111/j.1440-1746.1993.tb01179.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1746.1993.tb01179.x</ArticleId><ArticleId IdType="pubmed">8439667</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi A, Abe K, Saito R, Iwadate H, Okai K, Katsushima F, Monoe K, Kanno Y, Saito H, Kobayashi H, Watanabe H, Ohira H. Liver dysfunction in patients with systemic lupus erythematosus. Intern Med. 2013;52:1461&#x2013;1465. doi: 10.2169/internalmedicine.52.9458.</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.52.9458</ArticleId><ArticleId IdType="pubmed">23812192</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikpour M, Urowitz MB, Ibanez D, Gladman DD. Frequency and determinants of flare and persistently active disease in systemic lupus erythematosus. Arthritis Rheum. 2009;61:1152&#x2013;1158. doi: 10.1002/art.24741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.24741</ArticleId><ArticleId IdType="pubmed">19714602</ArticleId></ArticleIdList></Reference><Reference><Citation>Soares-Jr JM, Esposito SI, Nunes CJ, Ferreira FE, Dos SSR, Bonfa E, Silva CA, Baracat EC. Hormone therapy effect on menopausal systemic lupus erythematosus patients: a systematic review. Climacteric. 2022;25:427&#x2013;433. doi: 10.1080/13697137.2022.2050205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13697137.2022.2050205</ArticleId><ArticleId IdType="pubmed">35438053</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Lin S, Yang S, Chen L, Zheng X. Diagnostic value of serum complement C3 and C4 levels in Chinese patients with systemic lupus erythematosus. Clin Rheumatol. 2015;34:471&#x2013;477. doi: 10.1007/s10067-014-2843-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-014-2843-4</ArticleId><ArticleId IdType="pubmed">25597615</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukai M, Bohgaki T, Notoya A, Kohno M, Tateno M, Kobayashi S. Liver dysfunction due to apoptosis in a patient with systemic lupus erythematosus. Lupus. 2000;9:74&#x2013;77. doi: 10.1177/096120330000900115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/096120330000900115</ArticleId><ArticleId IdType="pubmed">10713652</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang D, Aghdassi E, Su J, Mosko J, Hirschfield GM, Gladman DD, Urowitz MB, Fortin PR. Prevalence and risk factors for liver biochemical abnormalities in Canadian patients with systemic lupus erythematosus. J Rheumatol. 2012;39:254&#x2013;261. doi: 10.3899/jrheum.110310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.110310</ArticleId><ArticleId IdType="pubmed">22174205</ArticleId></ArticleIdList></Reference><Reference><Citation>(2019) Guideline for diagnosis and treatment of liver failure. Zhonghua Gan Zang Bing Za Zhi 27:18&#x2013;26</Citation><ArticleIdList><ArticleId IdType="pubmed">30685919</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng XF, Chen YL (2020) 2020 guidelines for diagnosis and treatment of systemic lupus erythematosus in China. Chin J Intern Med 172&#x2013;173</Citation></Reference><Reference><Citation>Runyon BA, LaBrecque DR, Anuras S. The spectrum of liver disease in systemic lupus erythematosus. Report of 33 histologically-proved cases and review of the literature. Am J Med. 1980;69:187&#x2013;194. doi: 10.1016/0002-9343(80)90378-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9343(80)90378-2</ArticleId><ArticleId IdType="pubmed">7405944</ArticleId></ArticleIdList></Reference><Reference><Citation>Selmi C, Mackay IR, Gershwin ME. The immunological milieu of the liver. Semin Liver Dis. 2007;27:129&#x2013;139. doi: 10.1055/s-2007-979466.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2007-979466</ArticleId><ArticleId IdType="pubmed">17520513</ArticleId></ArticleIdList></Reference><Reference><Citation>(2010) Guidelines for the diagnosis and treatment of systemic lupus erythematosus. J Chin J Rheumatol 14:342&#x2013;346</Citation></Reference><Reference><Citation>Kwon OC, Kim YG, Park JH, Park MC. Seroconversion to antinuclear antibody negativity and its association with disease flare in patients with systemic lupus erythematosus. Lupus. 2020;29:697&#x2013;704. doi: 10.1177/0961203320917748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203320917748</ArticleId><ArticleId IdType="pubmed">32279583</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Tang Z, Shi Y, Ji L, Chen X, Chen Y, Wang X, Wang M, Wang W, Li D. Association between gamma-glutamyl transferase, total bilirubin and systemic lupus erythematosus in Chinese women. Front Immunol. 2021;12:682400. doi: 10.3389/fimmu.2021.682400.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.682400</ArticleId><ArticleId IdType="pmc">PMC8277571</ArticleId><ArticleId IdType="pubmed">34276670</ArticleId></ArticleIdList></Reference><Reference><Citation>Saenger AK. Discovery of the wonder drug: from cows to cortisone. The effects of the adrenal cortical hormone 17-hydroxy-11-dehydrocorticosterone (compound E) on the acute phase of rheumatic fever; preliminary report. Mayo Clin Proc 1949;24:277&#x2013;97. Clin Chem. 2010;56:1349&#x2013;1350. doi: 10.1373/clinchem.2010.149120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1373/clinchem.2010.149120</ArticleId><ArticleId IdType="pubmed">20538878</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang QB, He YL, Peng CM, Qing YF, He Q, Zhou JG. Systemic lupus erythematosus complicated by noncirrhotic portal hypertension: a case report and review of literature. World J Clin Cases. 2018;6:688&#x2013;693. doi: 10.12998/wjcc.v6.i13.688.</Citation><ArticleIdList><ArticleId IdType="doi">10.12998/wjcc.v6.i13.688</ArticleId><ArticleId IdType="pmc">PMC6232573</ArticleId><ArticleId IdType="pubmed">30430127</ArticleId></ArticleIdList></Reference><Reference><Citation>Liossis SN, Staveri C. What&#x2019;s new in the treatment of systemic lupus erythematosus. Front Med (Lausanne) 2021;8:655100. doi: 10.3389/fmed.2021.655100.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.655100</ArticleId><ArticleId IdType="pmc">PMC7973110</ArticleId><ArticleId IdType="pubmed">33748165</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Arruza I, Ugarte A, Cabezas-Rodriguez I, Medina JA, Moran MA, Ruiz-Irastorza G. Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2014;53:1470&#x2013;1476. doi: 10.1093/rheumatology/keu148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keu148</ArticleId><ArticleId IdType="pubmed">24681836</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao B, Zhang HY, Xie GJ, Liu HM, Chen Q, Li RF, You JP, Yang S, Mao Q, Zhang XQ. Evaluation of the efficacy of steroid therapy on acute liver failure. Exp Ther Med. 2016;12:3121&#x2013;3129. doi: 10.3892/etm.2016.3720.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2016.3720</ArticleId><ArticleId IdType="pmc">PMC5103754</ArticleId><ArticleId IdType="pubmed">27882127</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>